BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 34777458)

  • 1. Construction and Validation of a Novel Ferroptosis-Related lncRNA Signature to Predict Prognosis in Colorectal Cancer Patients.
    Zhang W; Fang D; Li S; Bao X; Jiang L; Sun X
    Front Genet; 2021; 12():709329. PubMed ID: 34777458
    [No Abstract]   [Full Text] [Related]  

  • 2. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNA Signatures Associated with Ferroptosis Predict Prognosis in Colorectal Cancer.
    Li N; Shen J; Qiao X; Gao Y; Su HB; Zhang S
    Int J Gen Med; 2022; 15():33-43. PubMed ID: 35018112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response.
    Li C; Zhang K; Gong Y; Wu Q; Zhang Y; Dong Y; Li D; Wang Z
    Front Pharmacol; 2023; 14():1200054. PubMed ID: 37377924
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
    Wei J; Zeng Y; Gao X; Liu T
    BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Pyroptosis-Associated Long Noncoding RNA Signature to Predict the Prognosis of Patients with Colorectal Cancer.
    Chen S; Zhu J; Zhi X
    Int J Gen Med; 2021; 14():6111-6123. PubMed ID: 34611426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
    Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
    Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
    [No Abstract]   [Full Text] [Related]  

  • 9. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostication of Pancreatic Cancer Using The Cancer Genome Atlas Based Ferroptosis-Related Long Non-Coding RNAs.
    Li J; Zhang J; Tao S; Hong J; Zhang Y; Chen W
    Front Genet; 2022; 13():838021. PubMed ID: 35237306
    [No Abstract]   [Full Text] [Related]  

  • 11. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 12. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
    Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
    BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma.
    Guo Y; Wang Z; Tian Y; Li L; Dong J
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Front Oncol; 2021; 11():663263. PubMed ID: 34123820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The construction of a novel ferroptosis-related lncRNA model to predict prognosis in colorectal cancer patients.
    Chen W; Deng J; Zhou Y
    Medicine (Baltimore); 2023 Mar; 102(10):e33114. PubMed ID: 36897681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs.
    Li C; Liu Q; Song Y; Wang W; Zhang X
    Front Oncol; 2022; 12():944476. PubMed ID: 36248984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer.
    Zhang K; Ping L; Du T; Liang G; Huang Y; Li Z; Deng R; Tang J
    Front Mol Biosci; 2021; 8():678877. PubMed ID: 34164433
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
    Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
    Front Genet; 2022; 13():938250. PubMed ID: 36561319
    [No Abstract]   [Full Text] [Related]  

  • 20. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma.
    Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S
    Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.